CSL CEO on Financial Results, Business Outlook

Feb. 12 (Bloomberg) -- Paul Perreault, chief executive officer of CSL Ltd., Australia's biggest pharmaceutical company, talks about its financial results and business outlook. CSL reported a 3.4 percent increase in first-half profit, helped by surging sales of an antidote for the blood-thinner warfarin. Perreault speaks from Melbourne with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)

Are Cloud Robotics Are a Game-Changer?
59:17 - “The Industries of the Future” Author Alec Ross discusses cloud robotics and the future of robot technology on “Bloomberg West.” (Source: Bloomberg)
  • Is There a Tech Talent Shortage in Silicon Valley?
  • Blackberry Cuts Jobs in Push to Profit
  • Bloomberg Businessweek: The Female Solidarity